Clinical Trial Update: The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating silymarin as adjuvant therapy for patients with metastatic colorectal cancer undergoing FOLFIRI treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Metastatic Colorectal Cancer | Phase 4 | Status: COMPLETED